Terns Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TERN and other ETFs, options, and stocks.About TERN
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program.
CEOAmy L. Burroughs
CEOAmy L. Burroughs
Employees66
Employees66
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded2017
Founded2017
Employees66
Employees66
TERN Key Statistics
Market cap374.79M
Market cap374.79M
Price-Earnings ratio-4.57
Price-Earnings ratio-4.57
Dividend yield—
Dividend yield—
Average volume644.31K
Average volume644.31K
High today$5.81
High today$5.81
Low today$5.47
Low today$5.47
Open price$5.47
Open price$5.47
Volume476.72K
Volume476.72K
52 Week high$13.51
52 Week high$13.51
52 Week low$3.26
52 Week low$3.26
Analyst ratings
75%
of 8 ratingsBuy
75%
Hold
25%
Sell
0%